Exploiting Longitudinal Speech Sessions via Voice Assistant Systems for Early Detection of Cognitive Decline
Authors:
Kristin Qi,
Jiatong Shi,
Caroline Summerour,
John A. Batsis,
Xiaohui Liang
Abstract:
Mild Cognitive Impairment (MCI) is an early stage of Alzheimer's disease (AD), a form of neurodegenerative disorder. Early identification of MCI is crucial for delaying its progression through timely interventions. Existing research has demonstrated the feasibility of detecting MCI using speech collected from clinical interviews or digital devices. However, these approaches typically analyze data…
▽ More
Mild Cognitive Impairment (MCI) is an early stage of Alzheimer's disease (AD), a form of neurodegenerative disorder. Early identification of MCI is crucial for delaying its progression through timely interventions. Existing research has demonstrated the feasibility of detecting MCI using speech collected from clinical interviews or digital devices. However, these approaches typically analyze data collected at limited time points, limiting their ability to identify cognitive changes over time. This paper presents a longitudinal study using voice assistant systems (VAS) to remotely collect seven-session speech data at three-month intervals across 18 months. We propose two methods to improve MCI detection and the prediction of cognitive changes. The first method incorporates historical data, while the second predicts cognitive changes at two time points. Our results indicate improvements when incorporating historical data: the average F1-score for MCI detection improves from 58.6% to 71.2% (by 12.6%) in the case of acoustic features and from 62.1% to 75.1% (by 13.0%) in the case of linguistic features. Additionally, the prediction of cognitive changes achieves an F1-score of 73.7% in the case of acoustic features. These results confirm the potential of VAS-based speech sessions for early detection of cognitive decline.
△ Less
Submitted 15 October, 2024;
originally announced October 2024.
The Alzheimer's Disease Prediction Of Longitudinal Evolution (TADPOLE) Challenge: Results after 1 Year Follow-up
Authors:
Razvan V. Marinescu,
Neil P. Oxtoby,
Alexandra L. Young,
Esther E. Bron,
Arthur W. Toga,
Michael W. Weiner,
Frederik Barkhof,
Nick C. Fox,
Arman Eshaghi,
Tina Toni,
Marcin Salaterski,
Veronika Lunina,
Manon Ansart,
Stanley Durrleman,
Pascal Lu,
Samuel Iddi,
Dan Li,
Wesley K. Thompson,
Michael C. Donohue,
Aviv Nahon,
Yarden Levy,
Dan Halbersberg,
Mariya Cohen,
Huiling Liao,
Tengfei Li
, et al. (71 additional authors not shown)
Abstract:
We present the findings of "The Alzheimer's Disease Prediction Of Longitudinal Evolution" (TADPOLE) Challenge, which compared the performance of 92 algorithms from 33 international teams at predicting the future trajectory of 219 individuals at risk of Alzheimer's disease. Challenge participants were required to make a prediction, for each month of a 5-year future time period, of three key outcome…
▽ More
We present the findings of "The Alzheimer's Disease Prediction Of Longitudinal Evolution" (TADPOLE) Challenge, which compared the performance of 92 algorithms from 33 international teams at predicting the future trajectory of 219 individuals at risk of Alzheimer's disease. Challenge participants were required to make a prediction, for each month of a 5-year future time period, of three key outcomes: clinical diagnosis, Alzheimer's Disease Assessment Scale Cognitive Subdomain (ADAS-Cog13), and total volume of the ventricles. The methods used by challenge participants included multivariate linear regression, machine learning methods such as support vector machines and deep neural networks, as well as disease progression models. No single submission was best at predicting all three outcomes. For clinical diagnosis and ventricle volume prediction, the best algorithms strongly outperform simple baselines in predictive ability. However, for ADAS-Cog13 no single submitted prediction method was significantly better than random guesswork. Two ensemble methods based on taking the mean and median over all predictions, obtained top scores on almost all tasks. Better than average performance at diagnosis prediction was generally associated with the additional inclusion of features from cerebrospinal fluid (CSF) samples and diffusion tensor imaging (DTI). On the other hand, better performance at ventricle volume prediction was associated with inclusion of summary statistics, such as the slope or maxima/minima of biomarkers. TADPOLE's unique results suggest that current prediction algorithms provide sufficient accuracy to exploit biomarkers related to clinical diagnosis and ventricle volume, for cohort refinement in clinical trials for Alzheimer's disease. However, results call into question the usage of cognitive test scores for patient selection and as a primary endpoint in clinical trials.
△ Less
Submitted 27 December, 2021; v1 submitted 9 February, 2020;
originally announced February 2020.
